This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Buiarelli F., Cartoni G., Coccioli F., Merolle M., Neri B.: Excretion Study of Stanozolol in Bovine by HPLC-Tandem Mass Spectrometry. Chromatographia 2004, 60, 545–555, doi: 10.1365/s10337-004-0400-z.BuiarelliF.CartoniG.CoccioliF.MerolleM.NeriB.:Excretion Study of Stanozolol in Bovine by HPLC-Tandem Mass Spectrometry.Chromatographia2004,60,545–555, doi:10.1365/s10337-004-0400-z.Open DOISearch in Google Scholar
Choi M.H., Chung B.C.: N-isobutyloxycarbonylation for improved detection of 3’-hydroxystanozolol and its 17-epimer in doping control. Analyst 2001, 126, 306–309, doi: 10.1039/b007929o.ChoiM.H.ChungB.C.:N-isobutyloxycarbonylation for improved detection of 3’-hydroxystanozolol and its 17-epimer in doping control.Analyst2001,126,306–309, doi:10.1039/b007929o.Open DOISearch in Google Scholar
Choo H.Y., Kwon O.S., Park J.: Quantitative determination of stanozolol and its metabolite in urine by gas chromatography/mass spectrometry. J Anal Toxicol 1990, 14, 109–112, doi: 10.1093/jat/14.2.109.ChooH.Y.KwonO.S.ParkJ.:Quantitative determination of stanozolol and its metabolite in urine by gas chromatography/mass spectrometry.J Anal Toxicol1990,14,109–112, doi:10.1093/jat/14.2.109.Open DOISearch in Google Scholar
Cirimele V., Kintz P., Ludes B.: Testing of the anabolic stanozolol in human hair by gas chromatography – negative ion chemical ionization mass spectrometry. J Chromatogr B 2000, 740, 265–271, doi: 10.1016/S0378-4347(00)00137-7.CirimeleV.KintzP.LudesB.:Testing of the anabolic stanozolol in human hair by gas chromatography – negative ion chemical ionization mass spectrometry.J Chromatogr B2000,740,265–271, doi:10.1016/S0378-4347(00)00137-7.Open DOISearch in Google Scholar
Clinton R.O., Manson A.J., Stonner F.W., Beyler A.L., Potts G.O., Arnold A.: Steroidal [3.2-c]Pyrazoles. J Am Chem Soc 1959, 81, 1513–1514, doi: 10.1021/ja01515a060.ClintonR.O.MansonA.J.StonnerF.W.BeylerA.L.PottsG.O.ArnoldA.:Steroidal [3.2-c]Pyrazoles.J Am Chem Soc1959,81,1513–1514, doi:10.1021/ja01515a060.Open DOISearch in Google Scholar
Commission of the European Communities: Commission Decision No. 2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretations of results. OJEC L 2002, 221, 15/08/2002, 8–36. http://data.europa.eu/eli/dec/2002/657/oj.Commission of the European Communities:Commission Decision No. 2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretations of results.OJEC L2002,221,15/08/2002,8–36. http://data.europa.eu/eli/dec/2002/657/oj.Search in Google Scholar
Council of the European Union: Council Directive 96/22/EC of 29 April 1996, concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC. OJEC L 1996, 125, 23/05/1996, 3–9. http://data.europa.eu/eli/dir/1996/22/oj.Council of the European Union:Council Directive 96/22/EC of 29 April 1996, concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC.OJEC L1996,125,23/05/1996,3–9. http://data.europa.eu/eli/dir/1996/22/oj.Search in Google Scholar
Council of the European Union: Council Directive 96/23/EC of 29 April 1996 on measures to monitor certain substances and residues thereof in live animals and animal products and repealing Directives 85/358/EEC and 86/469/EEC and Decisions 89/187/EEC and 91/664/EEC. OJEC L 1996, 125, 23/05/1996, 10–32. http://data.europa.eu/eli/dir/1996/23/oj.Council of the European Union:Council Directive 96/23/EC of 29 April 1996 on measures to monitor certain substances and residues thereof in live animals and animal products and repealing Directives 85/358/EEC and 86/469/EEC and Decisions 89/187/EEC and 91/664/EEC.OJEC L1996,125,23/05/1996,10–32. http://data.europa.eu/eli/dir/1996/23/oj.Search in Google Scholar
De Brabander H.F., De Wasch K., Van Ginkel L.A., Sterk S.S., Blokland M.H., Delahaut Ph., Taillieu X., Dubois M., Arts C.J.M., Van Baak M.J., Gramberg L.G., Schilt R., Van Bennekom E.O., Courtheyn D., Vercammen J., Witkamp R.F.: Multi-laboratory study of the analysis and kinetics of stanozolol and its metabolites in treated calves. Analyst 1998, 123, 2599–2604, doi: 10.1039/a805110k.De BrabanderH.F.De WaschK.Van GinkelL.A.SterkS.S.BloklandM.H.DelahautPh.TaillieuX.DuboisM.ArtsC.J.M.Van BaakM.J.GrambergL.G.SchiltR.Van BennekomE.O.CourtheynD.VercammenJ.WitkampR.F.:Multi-laboratory study of the analysis and kinetics of stanozolol and its metabolites in treated calves.Analyst1998,123,2599–2604, doi:10.1039/a805110k.Open DOISearch in Google Scholar
Deshmukh N.I., Zachar G., Petróczi A., Székely A.D., Barker J., Naughton D.P.: Determination of stanozolol and 3’-hydroxystanozolol in rat hair, urine and serum using liquid chromatography mass spectrometry. Chem Cent J 2012, 6, 162, doi: 10.1186/1752-153X-6-162.DeshmukhN.I.ZacharG.PetrócziA.SzékelyA.D.BarkerJ.NaughtonD.P.:Determination of stanozolol and 3’-hydroxystanozolol in rat hair, urine and serum using liquid chromatography mass spectrometry.Chem Cent J2012,6,162, doi:10.1186/1752-153X-6-162.Open DOISearch in Google Scholar
Directorate-General for Health and Consumers of the European Commission, Directorate E – Safety of the Food Chain: SANCO/2004/2726-rev 4 December 2008. Guidelines for the implementation of Decision 2002/657/EC. Directorate-General for Health and Consumers of the European Commission, Brussels, 2008, https://food.ec.europa.eu/system/files/2016-10/cs_vet-med-residues_cons_2004-2726rev4_en.pdf.Directorate-General for Health and Consumers of the European Commission,Directorate E – Safety of the Food Chain: SANCO/2004/2726-rev 4 December 2008. Guidelines for the implementation of Decision 2002/657/EC.Directorate-General for Health and Consumers of the European Commission,Brussels,2008, https://food.ec.europa.eu/system/files/2016-10/cs_vet-med-residues_cons_2004-2726rev4_en.pdf.Search in Google Scholar
Directorate-General for Health and Food Safety of the European Commission, European Union Reference Laboratories: EURL Guidance on Minimum Method Performance Requirements (MMPRs) for specific pharmacologically active substances in specific animal matrices, Version 2.0 June 2022. Directorate-General for Health and Food Safety, Brussels, 2022. https://eurl-residues.eu/wp-content/uploads/2022/06/EURL_MMPR_guidance_endorsed.pdf.Directorate-General for Health and Food Safety of the European Commission,European Union Reference Laboratories: EURL Guidance on Minimum Method Performance Requirements (MMPRs) for specific pharmacologically active substances in specific animal matrices, Version 2.0 June 2022.Directorate-General for Health and Food Safety,Brussels,2022. https://eurl-residues.eu/wp-content/uploads/2022/06/EURL_MMPR_guidance_endorsed.pdf.Search in Google Scholar
Douglas J.C., McCormick A., McConnell R.I., Lamont J.V., Fitzgerald S.P.: Development of an enzyme immunoassay for the screening of stanozolol in urine samples. In: Proceedings of the Euroresidue IV Conference on Residues of Veterinary Drugs in Food, 8–10 May 2000, Veldhoven, the Netherlands, Wageningen UR, Wageningen, 2000, pp 371–376.DouglasJ.C.McCormickA.McConnellR.I.LamontJ.V.FitzgeraldS.P.:Development of an enzyme immunoassay for the screening of stanozolol in urine samples. In:Proceedings of the Euroresidue IV Conference on Residues of Veterinary Drugs in Food, 8–10 May 2000, Veldhoven, the Netherlands,Wageningen UR, Wageningen,2000, pp371–376.Search in Google Scholar
Draisci R., Palleschi L., Marchiafava C., Ferretti E., Delli Quadri F.: Confirmatory analysis of residues of stanozolol and its major metabolite in bovine urine by liquid chromatographytandem mass spectrometry. J Chromatogr A 2001, 926, 69–77, doi: 10.1016/s0021-9673(01)00837-8.DraisciR.PalleschiL.MarchiafavaC.FerrettiE.Delli QuadriF.:Confirmatory analysis of residues of stanozolol and its major metabolite in bovine urine by liquid chromatographytandem mass spectrometry.J Chromatogr A2001,926,69–77, doi:10.1016/s0021-9673(01)00837-8.Open DOISearch in Google Scholar
Elbers I.J.W., Sterk S.S., van Ginkel L.A.: RIKILT report 2016.501: Proficiency test for A3 steroids in bovine urine. RIKILT Wageningen UR, Wageningen, 2016.ElbersI.J.W.SterkS.S.van GinkelL.A.:RIKILT report 2016.501: Proficiency test for A3 steroids in bovine urine.RIKILTWageningen UR, Wageningen,2016.Search in Google Scholar
European Commission: Commission Delegated Regulation (EU) 2022/1644 of 7 July 2022 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council with specific requirements for the performance of official controls on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof. OJEU L 2022, 248, 26/09/2022, 3–17. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32022R1644.European Commission:Commission Delegated Regulation (EU) 2022/1644 of 7 July 2022 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council with specific requirements for the performance of official controls on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof.OJEU L2022,248,26/09/2022,3–17. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32022R1644.Search in Google Scholar
European Commission: Commission Implementing Regulation (EU) 2021/808 of 22 March 2021 on the performance of analytical methods for residues of pharmacologically active substances used in food-producing animals and on the interpretation of results as well as on the methods to be used for sampling and repealing Decisions 2002/657/EC and 98/179/EC. OJEU L 2021, 180, 26/03/2021, 84–109. http://data.europa.eu/eli/reg_impl/2021/808/oj.European Commission:Commission Implementing Regulation (EU) 2021/808 of 22 March 2021 on the performance of analytical methods for residues of pharmacologically active substances used in food-producing animals and on the interpretation of results as well as on the methods to be used for sampling and repealing Decisions 2002/657/EC and 98/179/EC.OJEU L2021,180,26/03/2021,84–109. http://data.europa.eu/eli/reg_impl/2021/808/oj.Search in Google Scholar
European Commission: Commission Implementing Regulation (EU) 2022/1646 of 23 September 2022 on uniform practical arrangements for the performance of official controls as regards the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof, on specific content of multi-annual national control plans and specific arrangements for their preparation. OJEU L 2022, 248, 26/09/2022, 32–45. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32022R1646.European Commission:Commission Implementing Regulation (EU) 2022/1646 of 23 September 2022 on uniform practical arrangements for the performance of official controls as regards the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof, on specific content of multi-annual national control plans and specific arrangements for their preparation.OJEU L2022,248,26/09/2022,32–45. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32022R1646.Search in Google Scholar
European Food Safety Authority: Report for 2011 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products. EFSA supporting publication 2013, 10, EN-363, doi: 10.2903/sp.efsa.2013.EN-363.European Food Safety Authority:Report for 2011 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products.EFSA supporting publication2013,10, EN-363, doi:10.2903/sp.efsa.2013.EN-363.Open DOISearch in Google Scholar
European Parliament and the Council of the European Union: Directive 2003/74/EC of 22 September 2003 amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having hormonal or thyreostatic action and of beta agonists. OJEC L 2003, 262, 14/10/2003, 17-0021, https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32003L0074&from=en.European Parliament and the Council of the European Union:Directive 2003/74/EC of 22 September 2003 amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having hormonal or thyreostatic action and of beta agonists.OJEC L2003,262,14/10/2003, 17-0021, https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32003L0074&from=en.Search in Google Scholar
European Parliament and the Council of the European Union: Regulation (EU) 2017/625 of the European Parliament and of the Council of 15 March 2017 on official controls and other official activities performed to ensure the application of food and feed law, rules on animal health and welfare, plant health and plant protection products, amending Regulations (EC) No. 999/2001, (EC) No. 396/2005, (EC) No. 1069/2009, (EC) No. 1107/2009, (EU) No. 1151/2012, (EU) No. 652/2014, (EU) 2016/429 and (EU) 2016/2031 of the European Parliament and of the Council, Council Regulations (EC) No. 1/2005 and (EC) No. 1099/2009 and Council Directives 98/58/EC, 1999/74/EC, 2007/43/EC, 2008/119/EC and 2008/120/EC, and repealing Regulations (EC) No. 854/2004 and (EC) No. 882/2004 of the European Parliament and of the Council, Council Directives 89/608/EEC, 89/662/EEC, 90/425/EEC, 91/496/EEC, 96/23/EC, 96/93/EC and 97/78/EC and Council Decision 92/438/EEC (Official Controls Regulation). OJEU L 2017, 95, 07/04/2017, 1–142, http://data.europa.eu/eli/reg/2017/625/oj.European Parliament and the Council of the European Union:Regulation (EU) 2017/625 of the European Parliament and of the Council of 15 March 2017 on official controls and other official activities performed to ensure the application of food and feed law, rules on animal health and welfare, plant health and plant protection products, amending Regulations (EC) No. 999/2001, (EC) No. 396/2005, (EC) No. 1069/2009, (EC) No. 1107/2009, (EU) No. 1151/2012, (EU) No. 652/2014, (EU) 2016/429 and (EU) 2016/2031 of the European Parliament and of the Council, Council Regulations (EC) No. 1/2005 and (EC) No. 1099/2009 and Council Directives 98/58/EC, 1999/74/EC, 2007/43/EC, 2008/119/EC and 2008/120/EC, and repealing Regulations (EC) No. 854/2004 and (EC) No. 882/2004 of the European Parliament and of the Council, Council Directives 89/608/EEC, 89/662/EEC, 90/425/EEC, 91/496/EEC, 96/23/EC, 96/93/EC and 97/78/EC and Council Decision 92/438/EEC (Official Controls Regulation).OJEU L2017,95,07/04/2017,1–142, http://data.europa.eu/eli/reg/2017/625/oj.Search in Google Scholar
Ferchaud V., Le Bizec B., Montrade M.P., Maume D., Monteau F., Andre F.: Gas chromatographic-mass spectrometric identification of main metabolites of stanozolol in cattle after oral and subcutaneous administration. J Chromatogr B 1997, 695, 269–277, doi: 10.1016/S0378-4347(97)00124-2.FerchaudV.Le BizecB.MontradeM.P.MaumeD.MonteauF.AndreF.:Gas chromatographic-mass spectrometric identification of main metabolites of stanozolol in cattle after oral and subcutaneous administration.J Chromatogr B1997,695,269–277, doi:10.1016/S0378-4347(97)00124-2.Open DOISearch in Google Scholar
Furman B.L.: Stanozolol. In: xPharm: The Comprehensive Pharmacology Reference, edited by S.J. Enna, D.B. Bylund, Elsevier Science, Amsterdam, 2007, doi: 10.1016/B978-008055232-3.62675-3.FurmanB.L.:Stanozolol. In:xPharm: The Comprehensive Pharmacology Reference, edited byEnnaS.J.BylundD.B.,Elsevier Science,Amsterdam,2007, doi:10.1016/B978-008055232-3.62675-3.Open DOISearch in Google Scholar
International Organization for Standardization: ISO/11843-1:1997 Capability of detection–part 1: terms and definitions; ISO 11843-2:2000 Capability of detection–part 2: methodology in the linear calibration case (and technical Corrigendum-1: 2007). ISO, Geneva, 2007, http://www.iso.org/standard/1096.html; http://www.iso.org/standard/2186.html; http://www.iso.org/standard/50401.html.International Organization for Standardization:ISO/11843-1:1997 Capability of detection–part 1: terms and definitions; ISO 11843-2:2000 Capability of detection–part 2: methodology in the linear calibration case (and technical Corrigendum-1: 2007).ISO,Geneva,2007, http://www.iso.org/standard/1096.html; http://www.iso.org/standard/2186.html; http://www.iso.org/standard/50401.html.Search in Google Scholar
McKinney A.R., Suann C.J., Dunstan A.J., Mulley S.L., Ridley D.D., Stenhouse A.M.: Detection of stanozolol and its metabolites in equine urine by liquid chromatographyelectrospray ionization ion trap mass spectrometry. J Chromatogr B 2004, 811, 75–83, doi: 10.1016/j.jchromb.2004.02.045.McKinneyA.R.SuannC.J.DunstanA.J.MulleyS.L.RidleyD.D.StenhouseA.M.:Detection of stanozolol and its metabolites in equine urine by liquid chromatographyelectrospray ionization ion trap mass spectrometry.J Chromatogr B2004,811,75–83, doi:10.1016/j.jchromb.2004.02.045.Open DOISearch in Google Scholar
Mück W.M., Henion J.D.: High-performance liquid chromatography/tandem mass spectrometry: its use for the identification of stanozolol and its major metabolites in human and equine urine. Biomed Environ Mass Spectrom 1990, 19, 37–51, doi: 10.1002/bms.1200190106.MückW.M.HenionJ.D.:High-performance liquid chromatography/tandem mass spectrometry: its use for the identification of stanozolol and its major metabolites in human and equine urine.Biomed Environ Mass Spectrom1990,19,37–51, doi:10.1002/bms.1200190106.Open DOISearch in Google Scholar
Papich M.G.: Stanozolol. In: Saunders Handbook of Veterinary Drugs: Small and Large Animals, Fourth Edition, edited by M.G. Papich, Saunders Elsevier, St. Louis, 2016, pp. 740–742, doi: 10.1016/B978-0-323-24485-5.00522-2.PapichM.G.:Stanozolol. In:Saunders Handbook of Veterinary Drugs: Small and Large Animals,Fourth Edition, edited byPapichM.G.,Saunders Elsevier,St. Louis,2016, pp.740–742, doi:10.1016/B978-0-323-24485-5.00522-2.Open DOISearch in Google Scholar
Poelmans S., De Wasch K., De Brabander H.F., van De Viele M., Courtheyn D., Van Ginkel L.A., Sterk S.S., Delahaut Ph., Dubois M., Schilt R., Nielen M., Vercammen J., Impens S., Stephany R., Hamoir T., Pottie G., Van Poucke C., Van Peteghem C.: Analytical possibilities for the detection of stanozolol and its metabolites. Anal Chim Acta 2002, 473, 39–47, doi: 10.1016/S0003-2670(02)00672-4.PoelmansS.De WaschK.De BrabanderH.F.van De VieleM.CourtheynD.Van GinkelL.A.SterkS.S.DelahautPh.DuboisM.SchiltR.NielenM.VercammenJ.ImpensS.StephanyR.HamoirT.PottieG.Van PouckeC.Van PeteghemC.:Analytical possibilities for the detection of stanozolol and its metabolites.Anal Chim Acta2002,473,39–47, doi:10.1016/S0003-2670(02)00672-4.Open DOISearch in Google Scholar
Popielarska H., Myka A., Drabińska B., Gruszeczka A., Kruk J., Kurczab R., Kujawski J.: Pyrazole derivatives. A challenge of modern academic and industrial chemistry (in Polish). Przem Chem 2013, 92, 6, 905–914. http://docplayer.pl/1057008-Pochodne-pirazolowe-wyzwanie-wspolczesnej-chemii-akademickiej-i-przemyslowej.html.PopielarskaH.MykaA.DrabińskaB.GruszeczkaA.KrukJ.KurczabR.KujawskiJ.:Pyrazole derivatives. A challenge of modern academic and industrial chemistry (in Polish).Przem Chem2013,92,6,905–914. http://docplayer.pl/1057008-Pochodne-pirazolowe-wyzwanie-wspolczesnej-chemii-akademickiej-i-przemyslowej.html.Search in Google Scholar
Rijksinstituut voor Volksgezondheid en Milieu: Standard Operating Procedure ARO/446 of 26/01/2000: Analysis of stanozolol and metabolites in urine screening and quantification (LC-MSD) and confirmation (LC-MSn). RIVM, Bilthoven, 2000.Rijksinstituut voor Volksgezondheid en Milieu:Standard Operating Procedure ARO/446 of 26/01/2000: Analysis of stanozolol and metabolites in urine screening and quantification (LC-MSD) and confirmation (LC-MSn).RIVM,Bilthoven,2000.Search in Google Scholar
Rijksinstituut voor Volksgezondheid en Milieu: Standard Operating Procedure ARO/475B, Method validation using ResVal® .Validation according to EC/2002/657. RIVM, Bilthoven, 2004.Rijksinstituut voor Volksgezondheid en Milieu:Standard Operating Procedure ARO/475B, Method validation using ResVal® .Validation according to EC/2002/657.RIVM,Bilthoven,2004.Search in Google Scholar
Rijksinstituut voor Volksgezondheid en Milieu, Community Reference Laboratory: CRL Guidance Paper of 7 December 2007 – CRLs’ view on state-of-the-art analytical methods for national residue control plans. RIVM, Bilthoven, 2007. http://www.rivm.nl/bibliotheek/digitaaldepot/crlguidance2007.pdf.Rijksinstituut voor Volksgezondheid en Milieu,Community Reference Laboratory: CRL Guidance Paper of 7 December 2007 – CRLs’ view on state-of-the-art analytical methods for national residue control plans.RIVM,Bilthoven,2007. http://www.rivm.nl/bibliotheek/digitaaldepot/crlguidance2007.pdf.Search in Google Scholar
Thevis M., Fuβhöller G., Geyer H., Rodchenkov G., Mareck U., Sigmund G., Koch A., Thomas A., Schänzer W.: Detection of stanozolol and its major metabolites in human urine by liquid chromatography-tandem mass spectrometry. Chromatographia 2006, 64, 441–446, doi: 10.1365/s10337-006-0043-3.ThevisM.FuβhöllerG.GeyerH.RodchenkovG.MareckU.SigmundG.KochA.ThomasA.SchänzerW.:Detection of stanozolol and its major metabolites in human urine by liquid chromatography-tandem mass spectrometry.Chromatographia2006,64,441–446, doi:10.1365/s10337-006-0043-3.Open DOISearch in Google Scholar
Tolgyesi A., Sharma V.K., Fekete J.: Confirmatory analysis of stanozolol metabolites in bovine, pig, and sheep urines using an optimized clean-up and liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 2014, 88, 45–52, doi: 10.1016/j.jpba.2013.08.019.TolgyesiA.SharmaV.K.FeketeJ.:Confirmatory analysis of stanozolol metabolites in bovine, pig, and sheep urines using an optimized clean-up and liquid chromatography-tandem mass spectrometry.J Pharm Biomed Anal2014,88,45–52, doi:10.1016/j.jpba.2013.08.019.Open DOISearch in Google Scholar
Van de Wiele M., De Wasch K., Vercammen J., Courtheyn D., De Brabander H., Impens S.: Determination of 16beta-hydroxystanozolol in urine and faeces by liquid chromatographymultiple mass spectrometry. J Chromatogr A 2000, 904, 203–209, doi: 10.1016/s0021-9673(00)00945-6.Van de WieleM.De WaschK.VercammenJ.CourtheynD.De BrabanderH.ImpensS.:Determination of 16beta-hydroxystanozolol in urine and faeces by liquid chromatographymultiple mass spectrometry.J Chromatogr A2000,904,203–209, doi:10.1016/s0021-9673(00)00945-6.Open DOISearch in Google Scholar
World Anti-Doping Agency: 2020 Anti-Doping Testing Figures Report. World Anti-Doping Agency, Montreal, 2020. https://www.wada-ama.org/sites/default/files/2022-01/2020_anti-doping_testing_figures_en.pdf.World Anti-Doping Agency:2020 Anti-Doping Testing Figures Report.World Anti-Doping Agency,Montreal,2020. https://www.wada-ama.org/sites/default/files/2022-01/2020_anti-doping_testing_figures_en.pdf.Search in Google Scholar
World Anti-Doping Agency: World Anti-Doping Code International Standard Prohibited List. World Anti-Doping Agency, Montreal, 2022. https://www.wada-ama.org/sites/default/files/resources/files/2022list_final_en.pdf.World Anti-Doping Agency:World Anti-Doping Code International Standard Prohibited List.World Anti-Doping Agency,Montreal,2022. https://www.wada-ama.org/sites/default/files/resources/files/2022list_final_en.pdf.Search in Google Scholar